Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa by Amy S. Paller, Shireen V. Guide, Diego Ayala, Mercedes E. Gonzalez, Anne W. Lucky, Isin Sinem Bagci, M. Peter Marinkovich

Connect to this object online.

Mixed IgM- and IgA-mediated epidermolysis bullosa acquisita associated with IgM-λ paraproteinemia in an 81-year-old woman by Thinh Chau, MD, Joseph Wu, PhD, Benjamin Kahn, MD, Christopher Elco, MD, M. Peter Marinkovich, MD, Kerri E. Rieger, MD, PhD, Leslie Robinson-Bostom, MD, Elnaz F. Firoz, MD

Connect to this object online.

Mapping the burden of severe forms of epidermolysis bullosa - Implications for patient managementCapsule Summary by Jemima E. Mellerio, MD, Dimitra Kiritsi, MD, PhD, M. Peter Marinkovich, MD, Natividad Romero Haro, RN, Kellie Badger, RN, Meena Arora, MSc, Marc A. Dziasko, PhD, Mansi Vithlani, PhD, Anna E. Martinez

Connect to this object online.